Independence Blue Cross has instituted an 18-month benefit exclusion on certain drugs that receive accelerated approval from ...

The FDA wrapped up 2024 with 50 new drug approvals, clearing a wave of long-awaited treatments. Meanwhile, Transcarent will ...

According to the FDA, 1 each of the unapproved products were sold on the firm’s websites, Amazon shops, and social media ...

Amid recent backlash stemming from market withdrawals and trial delays, the FDA seeks to further clarify its requirements for ...

Colorado can better address the opioid crisis and equip organizations like IFC on the Hill with the tools to save lives.

Bryan Johnson, a tech entrepreneur, has stopped using rapamycin, a drug not approved for anti-aging by the FDA, following ...

The Food and Drug Administration has approved Unloxcyt (cosibelimab-ipdl) for advanced cutaneous squamous cell carcinoma.

On December 5, 2024, the U.S. Food and Drug Administration (FDA or Agency) issued a draft guidance entitled Expedited Program for ...

The FDA is expected to decide on treatments for Parkinson disease ... In Trial 072, treatment with brexpiprazole plus sertraline did not result in a statistically significant change in CAPS-5 total ...

In its second attempt, Takeda has secured FDA approval for Eohilia, which becomes the first and only oral therapy in the US for eosinophilic oesophagitis (EoE). The US regulator has cleared ...